Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterol-lowering therapy Academic Article uri icon

Overview

MeSH Major

  • Anticholesteremic Agents
  • Calcinosis
  • Coronary Artery Disease
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Hypercholesterolemia
  • Myocardial Infarction

abstract

  • Progression of CAC was significantly greater in patients receiving statins who had an MI compared with event-free subjects despite similar LDL control. Continued expansion of CAC may indicate failure of some patients to benefit from statin therapy and an increased risk of having cardiovascular events.

publication date

  • July 2004

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/01.ATV.0000127024.40516.ef

PubMed ID

  • 15059806

Additional Document Info

start page

  • 1272

end page

  • 7

volume

  • 24

number

  • 7